Cardiff Oncology, Inc. - Common Stock (CRDF)

CUSIP: 14147L108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
66,577,393
Total 13F shares
28,092,578
Share change
+11,431,752
Total reported value
$121,918,732
Put/Call ratio
23%
Price per share
$4.34
Number of holders
117
Value change
+$50,159,924
Number of buys
66
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 14147L108?
CUSIP 14147L108 identifies CRDF - Cardiff Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q4 2024

As of 31 Dec 2024, Cardiff Oncology, Inc. - Common Stock (CRDF) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,092,578 shares. The largest 10 holders included COMMODORE CAPITAL LP, BlackRock, Inc., Pfizer Inc, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, ACORN CAPITAL ADVISORS, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, MAI Capital Management, and STATE STREET CORP. This page lists 117 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.